591 
Impaired Glucose Tolerance and Other Metabolic Abnormalities in Adolescents and Young Adults with HIV Infection Acquired Perinatally or in Childhood
C Hadigan1, J Purdy2, C Worrell3, H Gebrehiwet2, and Rohan Hazra*2,3
1NIAID, NIH, Bethesda, MD, US; 2NCI, Bethesda, MD, US; and 3Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US
Background: Metabolic complications of ART may pose
a significant challenge for health maintenance among the emerging population of
young adults who acquired HIV in infancy or childhood. The purpose of this
study was to characterize the extent of metabolic abnormalities in a cohort of
HIV-infected patients who acquired HIV in infancy or childhood.
Methods: This is a cross-sectional study conducted
between 2004 and 2007 in which 40 patients (54% male, mean age 17 years, range
11 to 27 years; 38% black, 48% white, 8% mixed race, and 3% Hispanic) completed
oral glucose tolerance testing, fasting insulin, and lipid studies.
Additionally, anthropometric assessments including whole body dual-energy X-ray
absorptiometry (DEXA) scan were performed.
Results: All subjects were ART experienced with a
mean duration of 13.5 (2.6 [SD]) years; all had current or past protease
inhibitor (PI) and stavudine (d4T) exposure. One subject was not on ART; 88%
were currently on a PI. Half of the subjects had <50 HIV RNA (by polymerase
chain reaction) copies/mL, and the mean CD4 T cell count was 665 (416). Impaired
glucose tolerance was present in 20% of subjects; no subject had type-2
diabetes. Mean fasting insulin was 18.0 (13.7) IU/mL, glucose 86 (9) mg/dL, and
the mean homeostatic model for assessment of insulin resistance (HOMA) was
3.9(3.2). A HOMA value >4.0 is considered insulin resistant in adolescents; 38%
of subjects had a HOMA >4.0. Dyslipidemia was common; 50% had triglycerides ≥150
mg/dL, 53% had HDL cholesterol <50/40 mg/dL for females and males,
respectively, and 24% had total cholesterol ≥200 mg/dL. The mean body
mass index was 21.9 (3.6) kg/m2; 15% were overweight with a body
mass index >25 kg/m2, only 1 patient had a body mass index >30
kg/m2. The mean waist-to-hip ratio was 0.92 (0.07); 16% had a waist-to-hip
ratio >1.00, and the mean percentage of body fat by DEXA was 19.9 (8.7). There
was a significant positive correlation between waist-to-hip ratio and HOMA (r
= 0.39, p = 0.015).
Conclusions: Abnormal glucose homeostasis
characterized by impaired glucose tolerance and HOMA >4.0 was common among
heavily treated adolescents and young adults with HIV infection. Insulin
resistance was related to waist-to-hip ratio in this non-obese patient group. Dyslipidemia
was also common and similar to results from adult HIV+ cohorts.
These data demonstrate that long-term exposure to ART may convey substantial
metabolic risk including increased risk for subsequent type-2 diabetes and cardiovascular
disease. These findings warrant careful monitoring in this population as well
as further research.
|